DRKS00041144进行中（未招募）不适用
A prospective, randomized, controlled, multicenter study to evaluate the efficacy and safety of the designated Digital Application "OsteoCoach" for fall prevention, fracture prevention and enhanced mobility in older adults with osteoporosis
Osteoconnect GmbH0 个研究点目标入组 182 人开始时间: 2026年3月9日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 182
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 65 Years 至 —（—）
- 性别
- All
入选标准
- •Medically documented osteoporosis (ICD-10-GM M80.– or M81.–); access to a smartphone or tablet with an internet connection; sufficient digital literacy; sufficient spoken and written German language skills; written informed consent.
排除标准
- •Severe cognitive impairment preventing safe use; unstable cardiovascular disease; medical restriction against physical exertion; severe neurological dysfunction; other circumstances preventing use of the intervention.
研究者
相似试验
招募中
不适用
A Clinical Study to Evaluate the Efficacy and Safety of Pulmonary Rehabilitation Software EB-S100 in Patients with Chronic Obstructive Pulmonary DiseaseDiseases of the respiratory systemKCT0012275Emocog Co., Ltd.64
招募中
不适用
Phase III study of KD2-396Prevention of pertussis, diphtheria, tetanus, poliomyelitis(polio), Hib infection, and hepatitis BjRCT2031250804540
进行中（未招募）
3 期
A clinical study to evaluate the immunogenicity, safety and lot-to-lot
consistency of Measles, Mumps and Rubella vaccine in healthy infants aged 9-12 monthsCTRI/2026/07/113522Zydus Lifesciences Limited3,500
进行中（未招募）
不适用
Artificial Intelligence-Based Prediction of Invasion Depth in Superficial Esophageal CancerNeoplasmsKCT0012269Samsung Medical Center110
招募中
不适用
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerPIK3CA-mutated HER2-positive locally advanced or metastatic breast cancerjRCT2031250577230